Hepatocellular Carcinoma

Adjuvant treatment with atezolizumab and bevacizumab extended RFS compared with active surveillance among patients with hepatocellular carcinoma, according to study findings presented at AACR Annual Meeting.

Patients with hepatocellular carcinoma carried a “significantly higher” cancer-related financial burden compared with those with cirrhosis, according to data published in Clinical Gastroenterology and Hepatology.

A recent study found that Black women who smoked at the time of breast cancer diagnosis had a greater risk for all-cause mortality than those who never smoked, highlighting the importance of smoking cessation.

Single-fraction radiation therapy reduced hepatic pain among most patients with end-stage hepatocellular carcinoma or liver metastases, according to randomized phase 3 study results presented at ASCO Gastrointestinal Cancers Symposium.

Stereotactic body radiation therapy followed by sorafenib extended survival compared with sorafenib alone among patients with hepatocellular carcinoma, according to study results presented at ASCO Gastrointestinal Cancers Symposium.

Researchers have proposed a machine-learning algorithm for personalized treatment selection in patients with recurrent hepatocellular carcinoma, based on data published in JAMA Surgery.

Direct-acting antiviral treatment significantly lowered the risk for mortality and liver and non-liver outcomes in patients with chronic hepatitis C virus infection, regardless of disease stage, researchers reported.

Robotic liver resection for hepatocellular carcinoma yielded better perioperative tolerability and may be a safe and effective alternative to open liver resection, according to research published in JAMA Surgery.

Robotic liver dissection appeared safe and effective compared with open liver resection among patients with hepatocellular carcinoma, according to study results published in JAMA Surgery.

WASHINGTON — Increased culturally competent care and improved access to medical transport may improve early detection of hepatocellular carcinoma in patients who live in late-stage hotspots, according to researchers at The Liver Meeting.